|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||17.71 - 18.12|
|52-week range||16.34 - 19.60|
|Beta (5Y monthly)||0.27|
|PE ratio (TTM)||9.42|
|Forward dividend & yield||0.70 (3.78%)|
|Ex-dividend date||16 Nov 2023|
|1y target est||N/A|
Glaxo (GSK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here is how GSK (GSK) and Acadia Pharmaceuticals (ACAD) have performed compared to their sector so far this year.
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...